Home  |   Archive  |   Online Submission  |   News & Events  |   Subscribe  |   APFA  |   Society  |   Contact Us  |   中文版
Search   
 
Journal

Ahead of print
Authors' Accepted
    Manuscripts
new!
Current Issue
Archive
Acknowledgments
Special Issues
Browse by Category

Manuscript Submission

Online Submission
Online Review
Instruction for Authors
Instruction for Reviewers
English Corner new!

About AJA

About AJA
Editorial Board
Contact Us
News

Resources & Services

Advertisement
Subscription
Email alert
Proceedings
Reprints

Download area

Copyright licence
EndNote style file
Manuscript word template
Guidance for AJA figures
    preparation (in English)

Guidance for AJA figures
    preparation (in Chinese)

Proof-reading for the
    authors

AJA Club (in English)
AJA Club (in Chinese)

 
Abstract

Volume 10, Issue 5 (September 2008) 10, 765–769; 10.1111/j.1745-7262.2008.00390.x

Effect of testosterone on morphine withdrawal syndrome in rats

Ali Reza Mohajjel Nayebi and Hassan Rezazadeh

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz 51664, Iran

Correspondence: Dr Ali Reza Mohajjel Nayebi, Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz 51664, Iran. Fax: +98-411-3344-798. E-mail: nayebia@yahoo.com

Received 17 October 2007; Accepted 12 January 2008

Abstract

Aim: To determine whether testosterone is involved in morphine withdrawal syndrome (WS).

Methods: In order to induce dependency, rats were treated with subcutaneous injection of morphine (days 1–2, 5 mg/kg; days 3–5, 7.5 mg/kg; days 6–8, 10 mg/kg), and after the last dose of morphine (day 8) WS was induced by intraperitoneal injection of naloxone (1 mg/kg). Wet dog shake (WDS), abdomen writhing (AW), and jumps (J) were recorded as indicators of WS.

Results: The severity of WDS, AW, and J in male rats was greater than that in females. Accordingly, in 4-week castrated and flutamide-treated (10 mg/kg/day for 8 days, i.p.) male rats, WDS, AW, and J were significantly decreased compared to male control rats. Testosterone replacement therapy (10 mg/kg/day for 8 days, i.m.) in 4-week castrated rats restored the severity of WDS, AW, and J behaviors to the level of non-castrated male rats, whereas testosterone potentiated the WDS behavior in non-castrated male rats.

Conclusion: It can be concluded that testosterone might be effectively involved in morphine WS.

Keywords: testosterone, castration, flutamide, morphine, withdrawal syndrome

Full Text | PDF | 中文摘要 |

 
Browse:  5573
 
Asian Journal of Andrology CN 31-1795/R ISSN 1008-682X  Copyright © 2023  Shanghai Materia Medica, Chinese Academy of Sciences.  All rights reserved.